scholarly article | Q13442814 |
P356 | DOI | 10.1172/JCI115802 |
P953 | full work available at URL | https://europepmc.org/articles/PMC295896 |
https://europepmc.org/articles/PMC295896?pdf=render | ||
P932 | PMC publication ID | 295896 |
P698 | PubMed publication ID | 1376330 |
P5875 | ResearchGate publication ID | 21780043 |
P50 | author | Nancy Haigwood | Q55205394 |
P2093 | author name string | A. Takeda | |
F. A. Ennis | |||
D. D. Ho | |||
C. Debouck | |||
J. E. Robinson | |||
P2860 | cites work | Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies | Q27485071 |
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain | Q33880904 | ||
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS | Q34250436 | ||
Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro | Q36793253 | ||
Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. | Q36793493 | ||
Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody | Q40062738 | ||
Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell Lines | Q41736501 | ||
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry | Q42126903 | ||
Antibody-dependent enhancement of human immunodeficiency virus type 1 infection | Q43684895 | ||
HIV infection of monocytic cells: rôle of antibody-mediated virus binding to Fc-gamma receptors | Q44550044 | ||
Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies | Q44683552 | ||
Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome | Q45807119 | ||
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). | Q45839109 | ||
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro | Q45845087 | ||
The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells | Q46073217 | ||
A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A | Q68536789 | ||
Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies | Q69506281 | ||
Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization | Q69819599 | ||
Antibody-dependent enhancement of HIV infection | Q69918764 | ||
Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay | Q70074596 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
monoclonal antibody | Q422248 | ||
P304 | page(s) | 1952-1957 | |
P577 | publication date | 1992-06-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120 | |
P478 | volume | 89 |
Q35876233 | A novel antibody-dependent cellular cytotoxicity epitope in gp120 is identified by two monoclonal antibodies isolated from a long-term survivor of human immunodeficiency virus type 1 infection |
Q34009510 | A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection |
Q27485451 | Antibody-Dependent Enhancement of Hepatitis C Virus Infection |
Q36421569 | Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). |
Q24538755 | Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients |
Q45281480 | Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41. |
Q36549107 | Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope |
Q35890076 | Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody. |
Q45375987 | Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus |
Q38524329 | HIV-1 gp120: a novel viral B cell superantigen |
Q36649929 | Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo |
Q28236244 | Manipulation of cell surface macromolecules by flaviviruses |
Q33783763 | Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes |
Q24634681 | Pathogenesis of human immunodeficiency virus infection |
Search more.